Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hyperlactemia can predict the prognosis of liver resection.
Watanabe I, Mayumi T, Arishima T, Takahashi H, Shikano T, Nakao A, Nagino M, Nimura Y, Takezawa J. Watanabe I, et al. Among authors: shikano t. Shock. 2007 Jul;28(1):35-8. doi: 10.1097/shk.0b013e3180310ca9. Shock. 2007. PMID: 17510606
Middle pancreatectomy: safety and long-term results.
Shikano T, Nakao A, Kodera Y, Yamada S, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Takeda S. Shikano T, et al. Surgery. 2010 Jan;147(1):21-9. doi: 10.1016/j.surg.2009.04.036. Epub 2009 Aug 14. Surgery. 2010. PMID: 19682717
Cystic lymphangioma of the gallbladder: report of a case.
Shikano T, Takeda S, Sakai M, Sugimoto H, Kanazumi N, Nomoto S, Nakao A. Shikano T, et al. Surg Today. 2008;38(1):81-4. doi: 10.1007/s00595-007-3564-y. Epub 2007 Dec 24. Surg Today. 2008. PMID: 18085372
Combination of the tumor angiogenesis inhibitor bevacizumab and intratumoral oncolytic herpes virus injections as a treatment strategy for human gastric cancers.
Deguchi T, Shikano T, Kasuya H, Nawa A, Fujiwara S, Takeda S, Gewen T, Sahin TT, Yamada S, Kanzaki A, Yamamura K, Fujii T, Sugimoto H, Nomoto S, Fukuda S, Nishikawa Y, Kodera Y, Nakao A. Deguchi T, et al. Among authors: shikano t. Hepatogastroenterology. 2012 Sep;59(118):1844-50. doi: 10.5754/hge11566. Hepatogastroenterology. 2012. PMID: 22172413
Oncolytic herpes virus induces effective anti-cancer immunity against murine colon cancer.
Shirota T, Kasuya H, Kodera Y, Nishikawa Y, Shikano T, Sahin TT, Gewen T, Yamamura K, Fukuda S, Kanzaki A, Yamada S, Fujii T, Sugimoto H, Nomoto S, Takeda S, Nakao A. Shirota T, et al. Among authors: shikano t. Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1482-9. doi: 10.5754/hge11168. Epub 2011 Jul 15. Hepatogastroenterology. 2011. PMID: 21940320
Oncolytic virus therapy--foreword.
Kasuya H, Takeda S, Shimoyama S, Shikano T, Nomura N, Kanazumi N, Nomoto S, Sugimoto H, Nakao A. Kasuya H, et al. Among authors: shikano t. Curr Cancer Drug Targets. 2007 Mar;7(2):123-5. doi: 10.2174/156800907780058826. Curr Cancer Drug Targets. 2007. PMID: 17346102
A phase I dose-escalation clinical trial of intraoperative direct intratumoral injection of HF10 oncolytic virus in non-resectable patients with advanced pancreatic cancer.
Nakao A, Kasuya H, Sahin TT, Nomura N, Kanzaki A, Misawa M, Shirota T, Yamada S, Fujii T, Sugimoto H, Shikano T, Nomoto S, Takeda S, Kodera Y, Nishiyama Y. Nakao A, et al. Among authors: shikano t. Cancer Gene Ther. 2011 Mar;18(3):167-75. doi: 10.1038/cgt.2010.65. Epub 2010 Nov 19. Cancer Gene Ther. 2011. PMID: 21102422 Clinical Trial.
164 results